Ken Griffin Direxion Daily S&P Biotech Bea Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Citadel Advisors LLC holds 199,300 shares of LABD stock, worth $978,563. This represents 0.0% of its overall portfolio holdings.
Number of Shares
199,300
Previous 243,900
18.29%
Holding current value
$978,563
Previous $2.3 Million
35.19%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding LABD
# of Institutions
25Shares Held
1.48MCall Options Held
1.55MPut Options Held
269K-
Jane Street Group, LLC New York, NY337KShares$1.65 Million0.0% of portfolio
-
Virtu Financial LLC New York, NY260KShares$1.28 Million0.1% of portfolio
-
Chi Advisors LLC New York, NY225KShares$1.1 Million2.28% of portfolio
-
Jump Financial, LLC Chicago, IL174KShares$855,5130.02% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA54KShares$265,2480.0% of portfolio